Citiranje zadetka

Citação APA (7ª ed.)
Martin, T., Richardson, P. G., Facon, T., Moreau, P., Perrot, A., Spicka, I., . . . Suzuki, K. (2022). Primary outcomes by 1q21+ status for isatuximab-treated patients with relapsed/refractory multiple myeloma: Subgroup analyses from ICARIA-MM and IKEMA. Ferrata Storti Foundation.
Citação do estilo Chicago (17ª ed.)
Martin, Tom, et al. Primary Outcomes by 1q21+ Status for Isatuximab-treated Patients with Relapsed/refractory Multiple Myeloma: Subgroup Analyses from ICARIA-MM and IKEMA. Ferrata Storti Foundation, 2022.
Citação MLA (9ª ed.)
Martin, Tom, et al. Primary Outcomes by 1q21+ Status for Isatuximab-treated Patients with Relapsed/refractory Multiple Myeloma: Subgroup Analyses from ICARIA-MM and IKEMA. Ferrata Storti Foundation, 2022.
Opozorilo: Ti citati niso vedno 100% točni.